Advertisement
YOU ARE HERE: LAT HomeCollectionsPropulsid Drug
IN THE NEWS

Propulsid Drug

FEATURED ARTICLES
NEWS
January 25, 2000 | From Associated Press
The popular heartburn drug Propulsid can cause dangerous irregular heartbeats and even sudden death, the government said Monday, adding that the medicine should be used only as a last resort--and only by patients first given heart tests to ensure they are at low risk for the side effect.
ARTICLES BY DATE
BUSINESS
May 14, 2004 | From Associated Press
The Mississippi Supreme Court threw out a $48.5-million damage award against the makers of the heartburn drug Propulsid and ordered that separate trials be held for each of 10 plaintiffs. The justices, in the 6-1 decision, said it was improper to group the 10 plaintiffs together when their claims did not arise out of the same incident. Janssen Pharmaceutica Inc.
Advertisement
BUSINESS
May 14, 2004 | From Associated Press
The Mississippi Supreme Court threw out a $48.5-million damage award against the makers of the heartburn drug Propulsid and ordered that separate trials be held for each of 10 plaintiffs. The justices, in the 6-1 decision, said it was improper to group the 10 plaintiffs together when their claims did not arise out of the same incident. Janssen Pharmaceutica Inc.
NEWS
January 25, 2000 | From Associated Press
The popular heartburn drug Propulsid can cause dangerous irregular heartbeats and even sudden death, the government said Monday, adding that the medicine should be used only as a last resort--and only by patients first given heart tests to ensure they are at low risk for the side effect.
NEWS
December 20, 2000 | DAVID WILLMAN, TIMES STAFF WRITER
For most of its history, the United States Food and Drug Administration approved new prescription medicines at a grudging pace, paying daily homage to the physician's creed, "First, do no harm." Then in the early 1990s, the demand for AIDS drugs changed the political climate. Congress told the FDA to work closely with pharmaceutical firms in getting new medicines to market more swiftly. President Clinton urged FDA leaders to trust industry as "partners, not adversaries."
Los Angeles Times Articles
|